SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced the appointment of Amanda J. Redig, MD, PhD, as Chief Medical Officer. A medical oncologist and oncology drug developer, she brings extensive experience spanning academic medicine, drug development in both pharma and biotech, and life sciences investing. As a physician
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
